SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-05-003140
Filing Date
2005-03-15
Accepted
2005-03-15 16:26:48
Documents
12
Period of Report
2005-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y06203e10vk.txt 10-K 62993
2 DEFERRED FEE PLAN FOR DIRECTORS (AS AMENDED) y06203exv10wh.txt EX-10.H 14623
3 SUMMARY OF COMPENSATION y06203exv10wq.txt EX-10.Q 3834
4 STATEMENT OF COMPUTATION OF RATIO OF EARNINGS y06203exv12.txt EX-12 2665
5 PAGES 28-66 OF ANNUAL REPORT TO SHAREHOLDERS y06203exv13.txt EX-13 214644
6 SUBSIDIARIES y06203exv21.txt EX-21 17721
7 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM y06203exv23.txt EX-23 1233
8 CERTIFICATION y06203exv31wa.txt EX-31.A 3967
9 CERTIFICATION y06203exv31wb.txt EX-31.B 3968
10 CERTIFICATION y06203exv32wa.txt EX-32.A 1484
11 CERTIFICATION y06203exv32wb.txt EX-32.B 1486
12 CAUTIONARY STATEMENT PURSUANT TO PRIVATE SECURITIES y06203exv99wb.txt EX-99.B 7547
  Complete submission text file 0000950123-05-003140.txt   339045
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 7325242454
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0103
Type: 10-K | Act: 34 | File No.: 001-03215 | Film No.: 05682010
SIC: 2834 Pharmaceutical Preparations